Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
Magalie Dosset(University of California San Diego), Lionel Apétoh(Indiana University Health)
Cited by 11
Related Papers
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
|Annals of Oncology|2015|284
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T<sub>H</sub>1 and T<sub>H</sub>9 cells
|Journal for ImmunoTherapy of Cancer|2022|79
SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth
|Cancer Research|2013|52
CASM potentiates STING-driven NFκB signaling in immune cells
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0